Literature DB >> 11261094

Astrocytomas: the clinical picture.

R Strickler1, M L Phillips.   

Abstract

An astrocytoma is one of the most common brain tumors. Approximately 16,500 people will be diagnosed with brain cancer this year in the United States; of these, an estimated 13,000 will die. Astrocytomas originate from astrocytes in the central nervous system, and the maximum average life expectancy following an astrocytoma diagnosis is 18 months. Intracranial tumors often are devastating because of their growth and spread to vital centers, where they alter neurologic functions that make patients "people." Surgery, radiation, biotherapy, and chemotherapy are among the most common regimens used to treat these life-threatening intracranial tumors. Nurses caring for these patients play a vital role in providing pertinent interventions, emotional support, and end-of-life care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11261094

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

1.  Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients.

Authors:  Fatima W Khwaja; Matthew S Reed; Jeffrey J Olson; Brian J Schmotzer; G Yancey Gillespie; Abhijit Guha; Morris D Groves; Santosh Kesari; Jan Pohl; Erwin G Van Meir
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

2.  Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility.

Authors:  Vishwa Deep Dixit; Ashani T Weeraratna; Hyunwon Yang; Dorothy Bertak; Anthony Cooper-Jenkins; Gregory J Riggins; Charles G Eberhart; Dennis D Taub
Journal:  J Biol Chem       Date:  2006-03-09       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.